CBER Outlines Policy on Use of Standards in Drug Development, Reviews

Drug Industry Daily
A A
Drugmakers should use industry-driven voluntary standards but regulators will give priority to standards that are internationally harmonized, the FDA said in a final guidance issued Monday.

To View This Article:

Login

Subscribe To Drug Industry Daily